Highlights
- Market Cap
- $6.97B
- Enterprise Value
- $7.72B
- EPS (TTM)
- -$0.79
- Total Revenue (TTM)
- $319.02M
- Gross Profit (TTM)
- $37.90M
- EBITDA (TTM)
- -$162.48M
- Year Range
- $6.30 - $23.34
- ROA (TTM)
- -12.29%
- ROE (TTM)
- 29.98%
Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Core Scientific Inc. Tranche 2 Warrants, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
Core Scientific Inc. Tranche 2 Warrants (CORZZ) has returned 3.16% so far this year and 108.91% over the past 12 months.
Core Scientific Inc. Tranche 2 Warrants
- 1D
- 9.41%
- 1M
- -9.75%
- YTD
- 3.16%
- 6M
- -16.39%
- 1Y
- 108.91%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Jan 24, 2024, CORZZ's average daily return is +0.60%, while the average monthly return is +14.53%. At this rate, your investment would double in approximately 0.4 years.
Historically, 59% of months were positive and 41% were negative. The best month was May 2024 with a return of +135.4%, while the worst month was Mar 2025 at -35.2%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 4 months.
On a daily basis, CORZZ closed higher 52% of trading days. The best single day was Jun 6, 2024 with a return of +33.8%, while the worst single day was Jan 27, 2025 at -29.6%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 23.93% | -7.77% | -9.75% | 3.16% | |||||||||
| 2025 | -12.77% | -9.40% | -35.20% | 11.84% | 32.00% | 62.36% | -21.30% | 5.82% | 25.16% | 20.35% | -21.40% | -14.32% | 3.71% |
| 2024 | 48.75% | 18.03% | -16.67% | -34.17% | 135.44% | 133.60% | 11.74% | 6.08% | 14.17% | 12.76% | 34.39% | -21.32% | 754.72% |
Benchmark Metrics
Core Scientific Inc. Tranche 2 Warrants has an annualized alpha of 208.06%, beta of 2.58, and R² of 0.17 versus S&P 500 Index. Calculated based on daily prices since January 25, 2024.
- This stock captured 1809.36% of S&P 500 Index gains and 278.73% of its losses — amplifying both gains and losses, but participating more in upside than downside.
- R² of 0.17 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 208.06%
- Beta
- 2.58
- R²
- 0.17
- Upside Capture
- 1,809.36%
- Downside Capture
- 278.73%
Return for Risk
Risk / Return Rank
CORZZ ranks 79 for risk / return — better than 79% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Core Scientific Inc. Tranche 2 Warrants (CORZZ) and compare them to a chosen benchmark (S&P 500 Index).
| CORZZ | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.38 | 0.90 | +0.48 |
Sortino ratioReturn per unit of downside risk | 2.14 | 1.39 | +0.75 |
Omega ratioGain probability vs. loss probability | 1.27 | 1.21 | +0.06 |
Calmar ratioReturn relative to maximum drawdown | 2.53 | 1.40 | +1.13 |
Martin ratioReturn relative to average drawdown | 4.86 | 6.61 | -1.74 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore CORZZ risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the Core Scientific Inc. Tranche 2 Warrants. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Core Scientific Inc. Tranche 2 Warrants was 65.20%, occurring on Apr 8, 2025. Recovery took 128 trading sessions.
The current Core Scientific Inc. Tranche 2 Warrants drawdown is 34.78%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -65.2% | Nov 25, 2024 | 91 | Apr 8, 2025 | 128 | Oct 10, 2025 | 219 |
| -59.61% | Feb 13, 2024 | 44 | Apr 16, 2024 | 28 | May 24, 2024 | 72 |
| -40.39% | Nov 4, 2025 | 31 | Dec 17, 2025 | — | — | — |
| -29.96% | Jul 17, 2024 | 14 | Aug 5, 2024 | 31 | Sep 18, 2024 | 45 |
| -22.12% | Jun 17, 2024 | 5 | Jun 24, 2024 | 6 | Jul 2, 2024 | 11 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Core Scientific Inc. Tranche 2 Warrants over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Core Scientific Inc. Tranche 2 Warrants is priced in the market compared to other companies in the Software - Infrastructure industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for CORZZ relative to other companies in the Software - Infrastructure industry. Currently, CORZZ has a P/S ratio of 17.3. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |